SOLV
stock Healthcare Medical Instruments & SuppliesOverall Mixed · 59%
- Fundamentals Strong
- Trajectory Climbing
- Leadership Churning
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 4 of 5 trend signals bullishRSI 69 — firm momentum, not yet overbought.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $78.36
- +2.53%
- Close
- $78.36
- +2.53%
- Current
- $78.36
- Prev close
- $76.43
- Today
- 1.17M
- 3-mo avg
- 1.63M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- May 577 days ago
- Next expected
- Aug 4in 14 days · estimated from cadence
Recent earnings dates
- May 5 77 days ago
- Feb 26 145 days ago
- Nov 6, 2025 257 days ago
- Aug 7, 2025 348 days ago
Past earnings dates come from SOLV’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), SOLV’s fundamentals read as strong overall.
At 9.6x, the stock is priced cheaply against its profits: sometimes a bargain, sometimes a sign of trouble ahead.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
This company pays no dividend, common for firms reinvesting their profits back into growth.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 18.7% margin is strong; the company keeps a healthy slice of every revenue dollar.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 30.8% return on equity is strong; the company compounds owners' capital well.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 10.9% return on assets is strong; the company squeezes good profit from its assets.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 1.83, the company carries a moderate, manageable amount of debt.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.23, short-term assets cover short-term bills with a little room to spare.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 0.9% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 224.8% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | — | $8.1B | $8.2B | $8.3B | $8.3B |
| Net income | — | $1.3B | $1.3B | $479.0M | $1.6B |
| Diluted EPS | — | $7.78 | $7.79 | $2.76 | $8.88 |
| Dividend / share | — | — | — | — | — |
| Total assets | — | — | $13.9B | $14.5B | $14.3B |
| Total liabilities | — | — | $2.3B | $11.5B | $9.2B |
| Shareholder equity | $12.1B | $11.7B | $11.7B | $3.0B | $5.0B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.1B | $2.1B | $2.1B | $2.2B | $2.1B | $2.0B | $2.0B |
| Net income | $89.0M | $122.0M | $31.0M | $137.0M | $90.0M | $1.3B | $63.0M | $13.0M |
| Diluted EPS | $0.51 | $0.70 | $0.18 | $0.78 | $0.51 | $7.22 | $0.37 | $0.07 |
| Dividend / share | — | — | — | — | — | — | — | — |
Leadershipsynced from SEC 53d ago
- Alban Carlos Director
- Cox Carrie Smith Director
- Devore Susan D. Director
- Edwards Shirley Ann Director
- Eisenberg Glenn A Director
- Harris Bernard A Jr Director
- May Karen J Director
- Mily Elizabeth Director
- Weiland John H Director
- Wendell Amy Mcbride Director
Officers and board are drawn from SOLV’s recent SEC ownership filings (Forms 3, 4 and 5).
Notable recent eventspast year
- May 27 Officer or director change reported in an 8-K
- Mar 24 Officer or director change reported in an 8-K
- Mar 12 New 6-month low (-23% off peak)
- Feb 12 −6.8% one-day move
- Jan 13 −6.6% one-day move
- Dec 31, 2025 FY2025 net income +225% YoY
- Nov 7, 2025 +7.9% one-day move
- Nov 6, 2025 New 6-month low (-16% off peak)
- Oct 21, 2025 Officer or director change reported in an 8-K
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Recent SEC filingssynced from SEC 51d ago
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report